Qube Research & Technologies (QRT)
CNCE

Qube Research & Technologies (QRT)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-47,137
Closed -$275K – 3172
2022
Q4 		$275K Buy
47,137
+13,399
+40% +$70.5K ﹤0.01% 1680
2022
Q3 		$226K Buy
33,738
+7,115
+27% +$43.1K ﹤0.01% 1730
2022
Q2 		$112K Buy
+26,623
New +$105K ﹤0.01% 1902

Qube Research & Technologies (QRT)'s CNCE Position: Q1 2023 in Review

Qube Research & Technologies (QRT) sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 47,137 shares — an estimated $275K sold.

Qube Research & Technologies (QRT) first reported a position in CNCE in Q2 2022 and held it in 3 quarters. The position peaked at $275K in Q4 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

  • Qube Research & Technologies (QRT) reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 47,137 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $275K.
  • Qube Research & Technologies (QRT) first reported a position in Concert Pharmaceuticals, Inc. in Q2 2022 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Concert Pharmaceuticals, Inc. position peaked at $275K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.